ANAMAR AB
11Patents
10Active
11Granted
44Portfolio score
Filing activity: Apr 26, 2005 → Jun 22, 2016 · 7 expiring within 5 years
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8148429B2 | Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands | Chemistry; Metallurgy | 4 | Active |
| US8372878B2 | Aminoguanidines as melanocortin receptor ligands | Chemistry; Metallurgy | 3 | Active |
| US8663944B2 | Cartilage intermediate layer protein 2 C1 and its use to differentiate osteoarthritis from rheumatoid arthritis and non-disease conditions | Physics | 1 | Active |
| US8410174B2 | Method for treating arthritis | Chemistry; Metallurgy | 1 | Active |
| US8227502B2 | Amides acting on the adenosine receptors | Human Necessities | 1 | Active |
| US8309609B2 | Use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands | Chemistry; Metallurgy | 1 | Active |
| US8580529B2 | Diagnosis of collagen IX destruction | Physics | 1 | Active |
| US10544103B2 | 5-HT2 antagonists | Chemistry; Metallurgy | 0 | Active |
| US7956047B2 | Use of chondroitin sulphate E (CS-E) for the treatment of diseases or conditions related to collagen fibril formation | Human Necessities | 0 | Expired |
| US9227927B2 | Method of treating inflammation | Chemistry; Metallurgy | 0 | Active |
| US8110663B2 | Monoclonal antibodies for cartillage oligomeric matrix protein | Physics | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.